Integrated BioPharma, Inc. (INBP)

OTCMKTS: INBP · Delayed Price · USD
0.390
0.00 (0.00%)
Mar 28, 2023, 11:39 AM EDT - Market closed
Market Cap 13.18M
Revenue (ttm) 53.48M
Net Income (ttm) 2.20M
Shares Out 29.95M
EPS (ttm) 0.08
PE Ratio 5.06
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,500
Open 0.370
Previous Close 0.390
Day's Range 0.390 - 0.390
52-Week Range 0.270 - 0.830
Beta 0.44
Analysts n/a
Price Target n/a
Earnings Date n/a

About INBP

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutrition... [Read more]

Industry Packaged Foods
IPO Date Oct 29, 1996
Employees 147
Stock Exchange OTCMKTS
Ticker Symbol INBP
Full Company Profile

Financial Performance

In 2022, INBP's revenue was $56.25 million, a decrease of -11.51% compared to the previous year's $63.56 million. Earnings were $3.84 million, a decrease of -52.10%.

Financial Statements

News

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022. Revenue for th...

1 month ago - Accesswire

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022. Revenue for th...

4 months ago - Accesswire

7 Best Penny Stocks Under $1 to Buy in November

Despite warnings, investors still gravitate toward the realm of speculation, thereby necessitating a discussion about the best penny stocks under $1 to buy. To be clear, you don't want to participate ...

Other symbols: PFIE
5 months ago - InvestorPlace

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022. Re...

7 months ago - Accesswire

Integrated BioPharma Announces Change in Directors

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Bo...

10 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the ...

11 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for th...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Rev...

1 year ago - Accesswire

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: IN...

2 years ago - PRNewsWire